Clinical Trial

Therapeutic Efficacy of Different Wavelengths of Low-Level Laser Therapy in the Treatment of Cervicogenic Headache

Study acronym: WELL
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study tests if low-level laser therapy (LLLT) with different light wavelengths can help people with cervicogenic headache, a type of headache caused by neck problems. Adults aged 18-65 with this headache for at least 3 months will try one of three LLLT treatments (675nm, 820nm, or a mix of wavelengths) along with regular physical therapy like stretching and exercises. The study will check pain levels, how often headaches happen, neck movement, disability, and quality of life over 6 weeks, with follow-ups at 3 and 6 months. the investigators want to find the best LLLT option to reduce headache symptoms safely.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-31.
Trial Details
NCT Number NCT07163208
Lead Sponsor University of Lahore
Conditions Cervicogenic Headache
Enrollment 150 participants
Start Date 2024-09-05
Primary Completion 2025-09-30 (estimated)
Study Completion 2025-10-05 (estimated)
Updated on ClinicalTrials.gov 2025-09-19